{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:15:38Z","timestamp":1791976538266,"version":"4.4.0"},"reference-count":33,"publisher":"Wiley","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Reports in Medicine"],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:p>Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) widely used to alleviate pain and inflammation. Although it is generally considered safe, common adverse drug reactions of ibuprofen include stomach pain, nausea, and heartburn. It can also cause gastrointestinal (GI) bleeding, especially in individuals with a history of GI ulcers or bleeding disorders. Ibuprofen is predominantly metabolized by the cytochrome P450 (CYP) enzymes CYP2C9 and CYP2C8. Individuals carrying the CYP2C9\u22173 or CYP2C8\u22173 non-functional alleles have reduced enzyme activities resulting in elevated ibuprofen plasma concentrations and half-life. We presented a case of a 31-year-old Saudi female patient with a history of rheumatoid arthritis (RA) who had taken ibuprofen at 600\u2009mg twice daily for eight weeks. The patient presented to the emergency department with symptoms including nausea, vomiting, severe abdominal pain, and black tarry stools. An emergency esophagogastroduodenoscopy was performed on the patient, which revealed a deep bleeding ulcer measuring 1\u2009\u00d7\u20091\u2009cm in the antrum of the stomach. Laboratory investigations indicated anemia (hemoglobin: 7.21\u2009g\/dL and hematocrit: 22.40\u2009g\/dl). The patient received intravenous proton pump inhibitors and a packed red blood cell transfusion. Genetic analysis revealed that the patient was a carrier of CYP2C9\u22173 and CYP2C8\u22173 variant alleles, indicating that the patient is a poor metabolizer for both enzymes. The patient\u2019s symptoms improved over the subsequent days, and she was discharged with instructions to avoid NSAIDs. This is the first reported Saudi patient homozygous for CYP2C9\u22173 and CYP2C8\u22173 variant alleles, which led to ibuprofen-induced upper GI toxicity. This case demonstrates the importance of contemplating CYP2C9 and CYP2C8 genetic variations when administrating NSAIDs like ibuprofen. Careful assessment of the risks and benefits of NSAID therapy in each patient and consideration of alternative pain management strategies must be conducted when appropriate.<\/jats:p>","DOI":"10.1155\/2023\/6623269","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T16:35:07Z","timestamp":1689957307000},"page":"1-6","source":"Crossref","is-referenced-by-count":14,"title":["Association of CYP2C9\u22173 and CYP2C8\u22173 Non-Functional Alleles with Ibuprofen-Induced Upper Gastrointestinal Toxicity in a Saudi Patient"],"prefix":"10.1155","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1850-5686","authenticated-orcid":true,"given":"Amina M.","family":"Bagher","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.3310\/hta12110"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.794"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2006.05.019"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.18433\/j3t886"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261999"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000186"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.004671"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022970"},{"issue":"49","key":"10","first-page":"1897","article-title":"[The biotransformation of NSAIDs: a common elimination site and drug interactions]","volume":"122","author":"T. Leemann","year":"1992","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1515\/aiht-2016-67-2754"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.07.004"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02183.x"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.4103\/1735-5362.235165"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1160\/TH03-05-0325"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.40"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12654"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.05.025"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.04.006"},{"issue":"4","key":"20","first-page":"13","article-title":"Frequencies of cytochrome P450 2B6 and 2C8 allelic variants in the Mozambican population","volume":"20","author":"P. Arnaldo","year":"2013","journal-title":"Malaysian Journal of Medical Sciences"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2012.01606.x"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27291"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"24","article-title":"Allelic variants in the warfarin-related genes vkorc1 and cyp2c9 in a western saudi population","volume":"22","author":"M. A. Bagher","year":"2022","journal-title":"Journal of Pharmacol Pharmacother Forthcoming"},{"key":"25","volume-title":"The Clinically Relevant Cyp2c8 Polymorphisms In Saudi Pediatric Attending King Abdulaiziz","author":"A. M. Bagher","year":"2020"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f305a9"},{"key":"27","article-title":"Anatomical therapeutic chemical (atc)-classification with defined daily doses (ddd) index 2023","author":"World Health Organization","year":"2023"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.3389\/jpps.2023.11136"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1830"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2009.10"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4555"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36321"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.006452"}],"container-title":["Case Reports in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2023\/6623269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2023\/6623269.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2023\/6623269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T16:35:13Z","timestamp":1689957313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/crim\/2023\/6623269\/"}},"subtitle":[],"editor":[{"given":"Piotr K.","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":33,"alternative-id":["6623269","6623269"],"URL":"https:\/\/doi.org\/10.1155\/2023\/6623269","relation":{},"ISSN":["1687-9635","1687-9627"],"issn-type":[{"value":"1687-9635","type":"electronic"},{"value":"1687-9627","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}